{"id":"W4312139724","doi":"10.1136/ijgc-2022-igcs.5","title":"O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Placebo; Clinical endpoint; Oncology; Population; Discontinuation; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003671918,0.0002795612,0.001196076,0.0004171928,0.0001401242,0.00004815597,0.0005368633,0.0001044311,0.001734719],"category_scores_gemma":[0.001543758,0.0002281786,0.0006614626,0.0002381625,0.00007389417,0.00009230619,0.00009217724,0.000559291,0.000001381508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001395357,"about_ca_system_score_gemma":0.001012932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003276365,"about_ca_topic_score_gemma":0.0001034208,"domain_scores_codex":[0.9952666,0.0007276462,0.001683556,0.0004319923,0.001601275,0.0002889555],"domain_scores_gemma":[0.992931,0.004477536,0.001245461,0.0002545297,0.0008478074,0.0002436421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9768022,0.003397306,0.002065836,0.000005903937,0.001227611,0.0002379894,0.002033949,0.004423882,0.005397394,0.0000569106,0.001663433,0.002687631],"study_design_scores_gemma":[0.9662048,0.01217939,0.006124636,0.0001216334,0.0003055056,0.00002294049,0.0006332494,0.001169458,0.003212828,0.0003605807,0.009405423,0.000259538],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786494,0.0002326051,0.001907009,0.01162193,0.004030805,0.002650672,0.0007515213,0.00002007414,0.0001359536],"genre_scores_gemma":[0.9939981,0.00001605175,0.001605853,0.002513922,0.0007326587,0.000821178,0.00007952788,0.00003463266,0.0001980762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01534867,"threshold_uncertainty_score":0.9991778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07927624418906286,"score_gpt":0.4039022449466406,"score_spread":0.3246260007575777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}